VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 203 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $909 | 0.0% | 123 | 0.0% | 0.00% | – |
Q1 2023 | $909 | 0.0% | 123 | 0.0% | 0.00% | – |
Q4 2022 | $909 | -9.1% | 123 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | -85.7% | 123 | -80.2% | 0.00% | -100.0% |
Q2 2022 | $7,000 | 0.0% | 621 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $7,000 | -99.6% | 621 | -99.4% | 0.00% | -99.5% |
Q4 2021 | $1,645,000 | -9.4% | 104,889 | -1.0% | 0.39% | -18.0% |
Q3 2021 | $1,816,000 | -17.0% | 105,982 | +4.3% | 0.48% | -16.6% |
Q2 2021 | $2,187,000 | +8311.5% | 101,647 | +10064.7% | 0.57% | +4315.4% |
Q4 2018 | $26,000 | – | 1,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |